156 related articles for article (PubMed ID: 28337777)
21. Syringocystadenoma papilliferum of the scalp.
Perlman KL; Kentosh JB
Dermatol Online J; 2021 Mar; 27(3):. PubMed ID: 33865286
[TBL] [Abstract][Full Text] [Related]
22. Dermoscopy of syringocystadenoma papilliferum.
Lombardi M; Piana S; Longo C; Borsari S; Persechino F; Argenziano G; Moscarella E
Australas J Dermatol; 2018 Feb; 59(1):e59-e61. PubMed ID: 28695704
[TBL] [Abstract][Full Text] [Related]
23. Contiguous squamous proliferations in syringocystadenoma papilliferum: A retrospective study of 14 cases.
Aggarwal D; Chatterjee D; Keshavamurthy V; Chhikara K; Saikia UN; Radotra BD; De D; Singh MP
Indian J Dermatol Venereol Leprol; 2023; 89(2):266-273. PubMed ID: 34623039
[TBL] [Abstract][Full Text] [Related]
24. Ectopic hidradenoma papilliferum of eyelid: A rare entity with diagnostic challenge.
Shukla P; Malaviya AK
Indian J Pathol Microbiol; 2018; 61(2):287-289. PubMed ID: 29676381
[TBL] [Abstract][Full Text] [Related]
25. Sweat Gland Carcinoma With Neuroendocrine Differentiation of the Areola as a Potential Clinicopathologic Mimicker of Male Breast Carcinoma and Syringocystadenocarcinoma Papilliferum.
Bun S; Goto K; Oishi T; Kiyohara Y; Tsutsumida A; Yoshikawa S
Am J Dermatopathol; 2022 Nov; 44(11):850-854. PubMed ID: 35925548
[TBL] [Abstract][Full Text] [Related]
26. A Case of Syringocystadenocarcinoma Papilliferum: Not Your Usual Suspect.
Bashinskaya A; Shapiro L; Thompson C; Truett AP; Moody P
Cureus; 2023 May; 15(5):e39424. PubMed ID: 37362529
[TBL] [Abstract][Full Text] [Related]
27. Syringocystadenocarcinoma Papilliferum: A Rare Malignant Sweat Gland Tumor.
Yao JL; Cellura P; Phelps RG
Skinmed; 2018; 16(3):195-197. PubMed ID: 29989541
[TBL] [Abstract][Full Text] [Related]
28. Molecular Profiling of Syringocystadenocarcinoma Papilliferum Reveals RAS-Activating Mutations.
Cornejo KM; Hutchinson L; O'Donnell P; Meng X; Tomaszewicz K; Shalin SC; Cassarino DS; Chan MP; Quinn TR; Googe PB; Nazarian RM
Arch Pathol Lab Med; 2024 Feb; 148(2):215-222. PubMed ID: 37074845
[TBL] [Abstract][Full Text] [Related]
29. Syringocystadenoma papilliferum arising in a naevus sebaceous.
Faheem NAA; Kwan Z; Yong ASW; Ch'ng CC; Tan KK; Naicker M; Tan LL
Malays J Pathol; 2019 Apr; 41(1):47-49. PubMed ID: 31025637
[TBL] [Abstract][Full Text] [Related]
30. Syringocystadenoma Papilliferum of the External Auditory Canal.
Bruschini L; Ciabotti A; De Vito A; Forli F; Cambi C; Ciancia EM; Berrettini S
Am J Case Rep; 2017 May; 18():520-524. PubMed ID: 28490727
[TBL] [Abstract][Full Text] [Related]
31. [Anatomoclinical and immunohistochemical study of hidradenoma papilliferum, a tumor deriving from anogenital mammary-like glands].
Blind A; Weingertner N; Cribier B
Ann Dermatol Venereol; 2019 Sep; 146(8-9):528-536. PubMed ID: 31285043
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic pitfalls in syringocystadenocarcinoma papilliferum: case report and review of the literature.
Leeborg N; Thompson M; Rossmiller S; Gross N; White C; Gatter K
Arch Pathol Lab Med; 2010 Aug; 134(8):1205-9. PubMed ID: 20670144
[TBL] [Abstract][Full Text] [Related]
33. Syringocystadenoma papilliferum on the mons pubis.
Suzuki S; Al-Hajjaj S; Lee M; Bhawan J
Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906013
[TBL] [Abstract][Full Text] [Related]
34. Syringocystadenocarcinoma Papilliferum: Case Report and Review of the Literature.
Agulló Pérez AD; Bonaut Iriarte B; Córdoba Iturriagagoitia A; Valcayo Peñalba A
Actas Dermosifiliogr (Engl Ed); 2018 May; 109(4):366-369. PubMed ID: 29074144
[No Abstract] [Full Text] [Related]
35. Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases.
Alegría-Landa V; Jo-Velasco M; Santonja C; Eraña I; Vergara-Sanchez A; Kutzner H; Requena L
J Cutan Pathol; 2020 Jan; 47(1):12-16. PubMed ID: 31449665
[TBL] [Abstract][Full Text] [Related]
36. Eyelid syringocystadenoma papilliferum: A novel presentation with major review.
Tseng MC; Amin B; Barmettler A
Orbit; 2018 Jun; 37(3):171-174. PubMed ID: 29053036
[TBL] [Abstract][Full Text] [Related]
37. Syringocystadenocarcinoma papilliferum: successfully treated with Mohs micrographic surgery.
Chi CC; Tsai RY; Wang SH
Dermatol Surg; 2004 Mar; 30(3):468-71. PubMed ID: 15008887
[TBL] [Abstract][Full Text] [Related]
38. Contiguous verrucous proliferations in syringocystadenoma papilliferum: A retrospective analysis with additional evaluation via mutation-specific BRAFV600E immunohistochemistry.
Friedman BJ; Sahu J; Solomides CC; Connolly DM; Lee JB
J Cutan Pathol; 2018 Mar; 45(3):212-216. PubMed ID: 29206289
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic Study of Sialadenoma Papilliferum of the Minor Salivary Glands: A Series of 8 New Cases With BRAF V600E Mutation-specific Immunohistochemical Analysis.
Owosho AA; Shasteen AM; Aguirre SE; Summersgill KF
Int J Surg Pathol; 2023 Oct; 31(7):1265-1272. PubMed ID: 36632022
[No Abstract] [Full Text] [Related]
40. Metastatic Syringocystadenocarcinoma Papilliferum: A Case Report, Tumor Genomic Profiling, and Literature Review.
Altunel E; Perepletchikov A; Kozyreva O
Case Rep Oncol Med; 2020; 2020():9056209. PubMed ID: 32850165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
